AJCN EB Program 2010 Early Registration
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Silano, M.
Right arrow Articles by De Vincenzi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silano, M.
Right arrow Articles by De Vincenzi, M.
Agricola
Right arrow Articles by Silano, M.
Right arrow Articles by De Vincenzi, M.
American Journal of Clinical Nutrition, Vol. 87, No. 2, 415-423, February 2008
© 2008 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

A 10-residue peptide from durum wheat promotes a shift from a Th1-type response toward a Th2-type response in celiac disease1,2

Marco Silano, Rita Di Benedetto, Francesca Maialetti, Alessandro De Vincenzi, Roberta Calcaterra, Antonello Trecca and Massimo De Vincenzi

1 From the Division of Food Science, Human Nutrition and Health, Istituto Superiore di Sanità, Rome, Italy (MS, RdB, FM, and MdV); Fatebenefratelli Hospital, Rome, Italy (AdV); the San Gallicano Institute, Rome, Italy (RC); and the Division of Endoscopy and Operative Gastroenterology "Fabio Di Giovanbattista," International Health Care Center, Rome, Italy (AT)

Background: Celiac disease (CD) is a Th1-driven autoimmune permanent enteropathy that is triggered by dietary gluten. Molecules able to shift the immune response from a Th1- to a Th2-type response have been suggested as therapeutic agents for Th1 autoimmune diseases.

Objective: We sought to investigate the possibility that a decapeptide from durum wheat (p10mer, QQPQDAVQPF), which was previously shown to prevent the activation of celiac peripheral lymphocytes, may promote a shift from a Th1- to a Th2-type immune response in gluten-specific intestinal T cells of CD patients.

Design: Intestinal T lymphocyte lines derived from 8 children with CD were incubated with gliadin peptides both alone and simultaneously with p10mer. Cell proliferation and the production of interferon-{gamma} and interleukin-10 by these T cells were measured.

Results: The incubation of celiac intestinal T cells with deamidated gliadin peptides resulted in a significant (P < 0.008) increase in cell proliferation and interferon-{gamma} release, whereas the simultaneous exposure to p10mer totally abolished the cell proliferation and cytokine release. Moreover, incubation with p10mer maintained an elevated release of interleukin-10, whereas exposure of the cells to culture medium only did not. The replacement of the residues of aspartic acid in position 5 or those of alanine in position 6 in the sequence of p10mer resulted in peptides with no activity in the activation experiments.

Conclusion: In vitro, p10mer showed the ability to shift the pathogenic immune response of a CD patient from a Th1- to a Th2-type response.

Key Words: Th1-to-Th2 shift • gluten-specific T cells • celiac disease







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The American Society for Nutrition